当前位置:
X-MOL 学术
›
Nat. Rev. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options
Nature Reviews Gastroenterology & Hepatology ( IF 65.1 ) Pub Date : 2018-01-10 , DOI: 10.1038/nrgastro.2017.182 Alexander Semaan , Anirban Maitra
Nature Reviews Gastroenterology & Hepatology ( IF 65.1 ) Pub Date : 2018-01-10 , DOI: 10.1038/nrgastro.2017.182 Alexander Semaan , Anirban Maitra
Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options
中文翻译:
2017年的胰腺癌:重新启动胰腺癌的知识和治疗选择
2017年的胰腺癌:重新启动胰腺癌的知识和治疗选择
更新日期:2018-01-10
Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options, Published online: 10 January 2018; doi:10.1038/nrgastro.2017.182
High stromal cellularity in pancreatic cancer is an important factor for ineffective treatment and molecular studies. In 2017, major advancements were made in transcriptional characterization, treatment delivery and clinical regimes, raising hope for a breakthrough against this deadly disease.中文翻译:
2017年的胰腺癌:重新启动胰腺癌的知识和治疗选择
2017年的胰腺癌:重新启动胰腺癌的知识和治疗选择
2017年的胰腺癌:重新启动胰腺癌的知识和治疗选择,在线发布:2018年1月10日; doi:10.1038 / nrgastro.2017.182
胰腺癌的高基质细胞是无效治疗和分子研究的重要因素。2017年,在转录表征,治疗提供和临床方案方面取得了重大进展,为克服这一致命疾病带来了希望。